Fludarabine Phosphate (Teva Parenteral Medicines, Inc.)
Welcome to the PulseAid listing for the Fludarabine Phosphate drug offered from Teva Parenteral Medicines, Inc.. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Teva Parenteral Medicines, Inc. |
NON-PROPRIETARY NAME: | Fludarabine Phosphate |
SUBSTANCE NAME: | FLUDARABINE PHOSPHATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2004-05-01 |
END MARKETING DATE: | 2018-01-31 |
Fludarabine Phosphate HUMAN PRESCRIPTION DRUG Details:
Item Description | Fludarabine Phosphate from Teva Parenteral Medicines, Inc. |
LABELER NAME: | Teva Parenteral Medicines, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 25(mg/mL) |
START MARKETING DATE: | 2004-05-01 |
END MARKETING DATE: | 2018-01-31 |
PRODUCT ID: | 0703-4852_cd286651-0661-424a-985e-b68d1e5fc9a9 |
PRODUCT NDC: | 0703-4852 |
APPLICATION NUMBER: | ANDA076661 |
Other FLUDARABINE PHOSPHATE Pharmaceutical Manufacturers / Labelers: